CDH2 and pulmonary fibrosis: These findings demonstrated that, under TGF-β1 stimulation, the knockdown of these genes led to a significant decrease in the expression of fibrotic markers, highlighting the potential therapeutic relevance of targeting CALD1, CDH2, and POSTN for attenuating fibrotic processes in pulmonary fibrosis.